Boston Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Boston Advisors's MRK Position: Q3 2019 in Review
Boston Advisors reduced its Merck (MRK) stake by 13% in Q3 2019, selling an estimated $941K and leaving 77,787 shares worth $6.25M. The position accounts for 0.33% of the portfolio, ranked #83.
Boston Advisors first reported a position in MRK in Q2 2013 and has held it in 26 quarters since. The position peaked at $26.5M in Q4 2016. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.
- Boston Advisors held 77,787 shares of Merck worth $6.25M as of Q3 2019.
- Boston Advisors sold 11,747 Merck shares in Q3 2019, an estimated $941K.
- Merck made up 0.33% of Boston Advisors's portfolio in Q3 2019, its #83 holding.
- Boston Advisors first reported a position in Merck in Q2 2013 and has held it in 26 quarters since.
- Boston Advisors's Merck position peaked at $26.5M in Q4 2016.
- 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.
Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.